Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment

Abstract

A better survival was observed in men treated with a definitive therapy. The magnitude of the benefit on PCSM or ACM was similar for both definitive therapies irrespective of age.